Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

117.13 +3.14 (+2.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Illumina Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed. 
Via Benzinga
Topics Stocks
Exposures US Equities
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
Explore the dichotomy in the latest S&P 500 rally: Strong overall performance masks the underperformance of nearly half its stocks. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Illumina Inc Stock Is Falling
llumina, Inc. (NASDAQ: ILMN) shares are trading lower Friday after the company reported mixed third-quarter financial results on Thursday. 
Via Benzinga
DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance — Again
Illumina expects flat growth in 2024, which lines up with other life sciences tools companies. 
Via Investor's Business Daily
Where Illumina Stands With Analysts
Via Benzinga
Expert Ratings for Illumina
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Is the Worst Over for Illumina Stock?
There's reason to believe that the future is starting to look better. 
Via The Motley Fool
Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
US Stocks Could Wobble As Powell's Inflation Obsession Intensifies Rate Uncertainty: Will Nasdaq Wipe Off Week's Gains?
U.S. stocks are priming for a lackluster open on Friday, with the index futures trading on a narrowly mixed note. Interest rate worries have likely perked up, as reflected by the upward move in bond... 
Via Benzinga
Topics Bonds Economy
Exposures Debt Markets Interest Rates
Unity Software, Groupon, Trade Desk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded mixed this morning on Friday, with the Dow Jones futures gaining around 40 points this morning. Shares of Unity Software Inc. (NYSE: U) fell sharply in pre-market trading... 
Via Benzinga
Topics Stocks
Exposures US Equities
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co. 
Via Benzinga
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth 
Via InvestorPlace
Jim Cramer Highlights Key Earnings To Watch In The Energy Sector This Coming Week: 'Bullish Herd To Continue To Thunder'
CNBC market analyst Jim Cramer outlined the critical financial events and earnings disclosures anticipated in the upcoming week, spotlighting oil and gas companies such as Coterra Energy Inc. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 F-Rated Stocks to Sell Before November
Get rid of these F-rated stocks to sell so you can put that money into more lucrative opportunities in November. 
Via InvestorPlace
ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories
Bloomberg Apple and Suppliers Face Unanticipated Sales Slump Despite New Launches 
Via Benzinga
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Supply Chain
Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure
Illumina Inc (NASDAQ: ILMN) reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Bear Of The Day: Illumina
Illumina, the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen hard in the past year. 
Via Talk Markets
Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition
The European Union regulators are set to order Illumina Inc (NASDAQ: ILMN) to divest its acquisition of  
Via Benzinga
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly — So Many Of Us Use It'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said yes to The St. Joe Company (NYSE: JOE). "I’ve liked St. Joe forever," he added. 
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories
Benzinga 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.